Financial insights of MREO

MyFinsight

For the quarter ending 2026-03-31.

Income Statement	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Revenue	-	-250*	0	500
Cost of revenue	-	-65*	0	132
Research and development	4,747	4,193	4,270	5,373
General and administrative	4,019	4,197	6,045	5,494
Other income	-	184*	300	-
Loss from operations	-8,766	-8,391	-10,015	-10,499
Interest income	327	421	504	589
Interest expense	20	23	28	24
Changes in the fair value of warrants	17	294	196	-101
Foreign currency transaction gain/(loss), net	1,628	-126	1,873	-5,326
Benefit from research and development tax credit	95	474	446	745
Net loss before income tax	-6,719	-7,351	-7,024	-14,616
Income tax benefit	0	0	0	0
Net loss	-6,719	-7,351	-7,024	-14,616
Other comprehensive (loss)/income - foreign currency translation adjustments, net of tax	-1,748	87	-2,267	6,647
Total comprehensive loss	-8,467	-7,264	-9,291	-7,969

Basic EPS	-0.01	-0.009	-0.01	-0.02
Diluted EPS	-0.01	-0.009	-0.01	-0.02
Basic Average Shares	801,805,570	804,816,799	799,947,013	799,435,329
Diluted Average Shares	801,805,570	804,816,799	799,947,013	799,435,329

Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.